DocWire News Editors

DocwireNews

According to new data from the American Heart Association&rsquo;s COVID-19 Cardiovascular Disease Registry, Black and Hispanic patients accounted for more than half of hospitalizations and deaths due to COVID-19.James A. De Lemos, MD, professor of internal medicine in the division of cardiology at UT Southwestern Medical Center, presented these updates at a news briefing at the AHA Scientific Sessions 2020.&ldquo;Interventions aimed at reduce disparities will have to focus upstream from hospitalization,&rdquo; Dr. De Lemos said.The study looked at 7,868 patients hospitalized across 88 registry sites from January 1 to July 22, 2020. Among hospitalized patients, 33.0% were Hispanic, 25.5% were non-Hispanic Black, 6.3% were Asian and 35.2% were non-Hispanic white. The researchers compared the patients enrolled in the AHA COVID-19 CVD registry with population data from local census data.&nbsp; The study showed that Black and Hispanic patients accounted for more than half (~58%) of hospitalizations, a much higher proportion than in the communities where the hospitalization occurred.Hispanic patients were, on average, 12 years younger and Black patients were 9 years younger than white patients. The median age of patients hospitalized with COVID-19 was 69 years for non-Hispanic whites compared with only 60 years for Black patients and 57 years for Hispanic patients. Additionally, the probability of being uninsured or self-paying was significantly higher in Black (4.5%) or Hispanic (12.8%) patients compared with non-Hispanic white patients (2.5%).Obesity (49.3%), diabetes (45.2%) and hypertension (69.9%) were also most common among Black patients hospitalized with COVID-19 compared with non-Hispanic white patients (36.4%, 30.5%, 63.0%, respectively) and Hispanic patients (37.8%, 37.4%, 50.0%).Remdesivir was used slightly less frequently in Black patients than other groups (6.1% vs. 8.0% for non-Hispanic whites and 9.5% for Hispanic and 9.2% for Asian Pacific Islander patients). Black patients were more likely to require a ventilator or kidney dialysis.After multivariable adjustment there were no differences by race or ethnic group &nbsp;for in-hospital mortality or in the probability of major adverse cardiovascular events. A modified disease severity scale showed slightly higher disease severity in Asian Pacific Islanders, but there was no difference in Black or Hispanic patients. &nbsp;Fifty-three percent of deaths that occurred in hospitalized patients with COVID-19 occurred in Black and Hispanic patients.&ldquo;The results highlight the disproportionate burden of COVID-19 especially among Black and Hispanic communities and imply there are factors in the U.S. that existed prior to a coronavirus diagnosis that are driving these disparities,&rdquo; said the study&rsquo;s lead author Fatima Rodriguez, MD, MPH, an assistant professor in cardiovascular medicine at Stanford University Medical Center in Palo Alto, California.

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Blacks, Hispanics Had Higher Rates of Hospitalization, Mortality from COVID-19

AHA Scientific Sessions 2020

According to new data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, Black and Hispanic patients accounted for more than half of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe